DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Long A, Rahmaoui A, Rothman KJ. , et al.
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab.
J Allergy Clin Immunol 2014;
134 (03) 560-567.e4
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.